Patient Square Capital Lp Top Holdings and 13F Report (2025) About Patient Square Capital LpInvestment ActivityPatient Square Capital Lp has $267.37 million in total holdings as of December 31, 2024.Patient Square Capital Lp owns shares of 20 different stocks, but just 6 companies or ETFs make up 80% of its holdings.Approximately 19.74% of the portfolio was purchased this quarter.About 23.66% of the portfolio was sold this quarter.This quarter, Patient Square Capital Lp has purchased 11 new stocks and bought additional shares in 9 stocks.Patient Square Capital Lp sold shares of 2 stocks and completely divested from 0 stocks this quarter.Largest Holdings Roivant Sciences $147,638,400Liquidia $21,877,963Insmed $21,206,810Cullinan Therapeutics $10,704,965EyePoint Pharmaceuticals $10,506,966 Largest New Holdings this Quarter Intra-Cellular Therapies $6,012,605 HoldingGeron $4,677,289 HoldingAgios Pharmaceuticals $4,000,114 HoldingDisc Medicine $3,575,760 HoldingSpringWorks Therapeutics $3,365,040 Holding Largest Purchases this Quarter Insmed 135,463 shares (about $9.35M)Intra-Cellular Therapies 71,990 shares (about $6.01M)Geron 1,321,268 shares (about $4.68M)Agios Pharmaceuticals 121,732 shares (about $4.00M)Disc Medicine 56,400 shares (about $3.58M) Largest Sales this Quarter Liquidia 5,322,161 shares (about $62.59M)Pharvaris 34,738 shares (about $665.93K) Sector Allocation Over TimeMap of 500 Largest Holdings ofPatient Square Capital Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorROIVRoivant Sciences$147,638,400$2,975,659 ▲2.1%12,480,00055.2%MedicalLQDALiquidia$21,877,963$62,588,613 ▼-74.1%1,860,3718.2%MedicalINSMInsmed$21,206,810$9,352,366 ▲78.9%307,1677.9%MedicalCGEMCullinan Therapeutics$10,704,965$660,059 ▲6.6%878,8974.0%MedicalEYPTEyePoint Pharmaceuticals$10,506,966$360,222 ▲3.6%1,410,3313.9%MedicalNRIXNurix Therapeutics$8,408,217$2,270,352 ▲37.0%446,2963.1%MedicalITCIIntra-Cellular Therapies$6,012,605$6,012,605 ▲New Holding71,9902.2%MedicalELVNEnliven Therapeutics$5,040,855$3,002,985 ▲147.4%224,0381.9%MedicalGERNGeron$4,677,289$4,677,289 ▲New Holding1,321,2681.7%MedicalOCULOcular Therapeutix$4,021,648$2,010,495 ▲100.0%470,9191.5%MedicalAGIOAgios Pharmaceuticals$4,000,114$4,000,114 ▲New Holding121,7321.5%MedicalPHVSPharvaris$3,979,750$665,928 ▼-14.3%207,6031.5%MedicalIRONDisc Medicine$3,575,760$3,575,760 ▲New Holding56,4001.3%MedicalSWTXSpringWorks Therapeutics$3,365,040$3,365,040 ▲New Holding93,1371.3%MedicalALLOAllogene Therapeutics$3,173,506$3,173,506 ▲New Holding1,489,9091.2%MedicalMIRMMirum Pharmaceuticals$2,683,615$2,683,615 ▲New Holding64,9001.0%MedicalNTLAIntellia Therapeutics$2,518,338$1,019,224 ▲68.0%215,9810.9%MedicalARVNArvinas$1,660,640$1,660,640 ▲New Holding86,6270.6%MedicalSRRKScholar Rock$1,383,040$1,383,040 ▲New Holding32,0000.5%MedicalATXSAstria Therapeutics$939,210$586,777 ▲166.5%105,0570.4%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
